Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients
- 20 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Cancer Biology & Therapy
- Vol. 21 (5), 391-399
- https://doi.org/10.1080/15384047.2019.1704122
Abstract
Patients with high-risk neuroblastoma (HR-NB) often initially respond to therapy, but afterward they become resistant and disease recurred. Unfortunately, it does not exist one or more specific chromosome defects associated with relapse or refractory NB. Recently, genomic evidence from primary tumors indicated that the distal region of chromosome 6q is loss in HR-NB patients with fatal outcome. We identified a minimal common region of loss of chromosome 6q27 spanning an area of 2.09 Mb by high-resolution DNA copy number data of a small cohort of HR-NB samples carrying 6q loss. This region of loss harbored five genes T, SFT2D1, RPS6KA2, FGFR1OP, and UNC93A. We found that low SFT2D1, RPS6KA2, and FGFR1OP gene expression predicted poor outcome in HR-NB patients using public R2 Platform. Further functional studies will be essential to confirm the presumed tumor suppressor gene(s) located within 6q27 region. These results suggest that SFT2D1, RPS6KA2, and FGFR1OP genes may be responsible for poor prognosis of HR-NB tumors with 6q27 loss, and their haploinsufficiency may be crucial in accelerating tumor progression.Keywords
This publication has 30 references indexed in Scilit:
- The challenge of defining "ultra-high-risk" neuroblastomaPediatric Blood & Cancer, 2019
- NeuroblastomaPediatric Clinics of North America, 2015
- Neuroblastoma: developmental biology, cancer genomics and immunotherapyNature Reviews Cancer, 2013
- Treatment and outcomes of patients with relapsed, high‐risk neuroblastoma: Results of German trialsPediatric Blood & Cancer, 2010
- Recent Advances in NeuroblastomaThe New England Journal of Medicine, 2010
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97Journal of Clinical Oncology, 2008
- Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaThe New England Journal of Medicine, 2005
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaThe New England Journal of Medicine, 1999
- Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaThe New England Journal of Medicine, 1996